Libentech - About the company
Libentech is a funded company based in Yuseong District (South Korea), founded in 2020. It operates as a Provider of biopharmaceutical product development services. The company has 1977 active competitors, including 452 funded and 333 that have exited. Its top competitors include companies like Antheia, Transcenta and Akeso.
Company Details
Libentech is a provider of biopharmaceutical product development services. The company has different technology platforms like oncolytic virus platform, gene delivery platform, and recombinant protein expression. It provides services like biobanking, production process development, separation and purification technology development, clinical sample production and construction of protein expression systems.
- Website
- libentech.kr
- Email ID
- *****@naver.com
- Phone Number
- +82 **********
Key Metrics
Founded Year
2020
Location
Yuseong District, South Korea
Stage
Funding Raised
Investors
Ranked
1717th among 1977 active competitors
Sign up to download Libentech's company profile
Libentech's funding and investors
Libentech is a funded company. Libentech has 1 institutional investor.
View details of Libentech's funding rounds and investors
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Libentech's Competitors and alternates
Top competitors of Libentech include Antheia, Transcenta and Akeso. Here is the list of Top 10 competitors of Libentech, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Antheia 2013, Palo Alto (United States), Series C | Genetically engineered yeast cells to produce medicinal products | $176M | 67/100 | |
2nd | Transcenta 2019, Suzhou (China), Public | Developer of antibody-based therapeutics | $205M | 66/100 | |
3rd | Developer of antibody drug conjugates for the treatment of broad spectrum diseases | $195M | 65/100 | ||
4th | Korro Bio 2018, Cambridge (United States), Public | Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases | $4M | 64/100 | |
5th | Fermentalg 2005, Libourne (France), Public | Innovating with algae for sustainable solutions in nutrition and environmental impact | $30.3M | 63/100 | |
6th | Microban 1994, Huntersville (United States), Acquired | Antimicrobial and odor control technologies for durable product protection and freshness | $64.6M | 63/100 | |
7th | Dewpoint Therapeutics 2018, Boston (United States), Series D | Developer of small molecule based therapeutics | $364M | 62/100 | |
8th | One Biosciences 2020, Paris (France), Series A | Developer of single-cell therapeutics solutions to treat multiple health disorders | $22.4M | 62/100 | |
9th | Developer of oral non-viral gene therapy platform | $54M | 61/100 | ||
10th | Avalyn Pharma 2011, Seattle (United States), Public | Developer of therapies for the treatment of Idiopathic Pulmonary Fibrosis | $389M | 61/100 | |
1717th | Libentech 2020, Yuseong District (South Korea), Funding Raised | Provider of biopharmaceutical product development services | - | 22/100 |
_1523881431192.png?devicePixelRatio=2&height=30&width=30){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Libentech's competitors? Click here to see the top ones
Libentech's Investments and acquisitions
Libentech has made no investments or acquisitions yet.
Reports related to Libentech
Here is the latest report on Libentech's sector:
Are you a Founder ?
FAQs about Libentech
Explore our recently published companies
- Economies d'energies - France based, Unfunded company
- Berryville Farm and Pet Supply - Berryville based, 2020 founded, Deadpooled company
- Smart Wealth Pro - Unfunded company
- Martexim - Jaipur based, 2020 founded, Unfunded company
- Montana Consulting - Unfunded company
- Taka Consultants - Unfunded company
